NCT00003569View on ClinicalTrials.gov

Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

June 30, 2003

Conditions

Head and Neck CancerLung CancerNeurotoxicityOvarian Cancer

Interventions

DRUG

cisplatin

DRUG

dimesna

DRUG

paclitaxel

Trial Locations (3)

60637-1470

University of Chicago Cancer Research Center, Chicago

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00003569 - Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel | Biotech Hunter | Biotech Hunter